Walleye Capital LLC Lantheus Holdings, Inc. Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $270,802 - $382,030	4,600 Added 22.66%	24,900 $2 Million
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $265,564 - $354,952	-5,200 Reduced 20.39%	20,300 $1.26 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $216,840 - $303,771	-3,900 Reduced 13.27%	25,500 $1.58 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $3.2 Million - $4.82 Million	-53,100 Reduced 64.36%	29,400 $2.04 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $6.5 Million - $7.86 Million	78,900 Added 2191.67%	82,500 $6.92 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $57,312 - $99,432	1,200 Added 50.0%	3,600 $297,000
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $1.45 Million - $2.31 Million	-29,800 Reduced 92.55%	2,400 $122,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $1.98 Million - $2.78 Million	32,200 New	32,200 $2.27 Million

495

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.54B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.